Most cited article - PubMed ID 37130759
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with patients having unresectable or metastatic disease at diagnosis, with poor prognosis and very short survival. Given that genetic variation within autophagy-related genes influences autophagic flux and susceptibility to solid cancers, we decided to investigate whether 55,583 single nucleotide polymorphisms (SNPs) within 234 autophagy-related genes could influence the risk of developing PDAC in three large independent cohorts of European ancestry including 12,754 PDAC cases and 324,926 controls. The meta-analysis of these populations identified, for the first time, the association of the BIDrs9604789 variant with an increased risk of developing the disease (ORMeta = 1.31, p = 9.67 × 10-6). We also confirmed the association of TP63rs1515496 and TP63rs35389543 variants with PDAC risk (OR = 0.89, p = 6.27 × 10-8 and OR = 1.16, p = 2.74 × 10-5). Although it is known that BID induces autophagy and TP63 promotes cell growth, cell motility and invasion, we also found that carriers of the TP63rs1515496G allele had increased numbers of FOXP3+ Helios+ T regulatory cells and CD45RA+ T regulatory cells (p = 7.67 × 10-4 and p = 1.56 × 10-3), but also decreased levels of CD4+ T regulatory cells (p = 7.86 × 10-4). These results were in agreement with research suggesting that the TP63rs1515496 variant alters binding sites for FOXA1 and CTCF, which are transcription factors involved in modulating specific subsets of regulatory T cells. In conclusion, this study identifies BID as new susceptibility locus for PDAC and confirms previous studies suggesting that the TP63 gene is involved in the development of PDAC. This study also suggests new pathogenic mechanisms of the TP63 locus in PDAC.
- Keywords
- autophagy, functional characterization, genetic variants, pancreatic cancer, polymorphisms, susceptibility,
- MeSH
- Autophagy * genetics MeSH
- White People genetics MeSH
- Carcinoma, Pancreatic Ductal * genetics pathology MeSH
- Forkhead Transcription Factors MeSH
- Genetic Predisposition to Disease * MeSH
- Hepatocyte Nuclear Factor 3-alpha genetics metabolism MeSH
- Polymorphism, Single Nucleotide * MeSH
- Cohort Studies MeSH
- Humans MeSH
- Biomarkers, Tumor * genetics MeSH
- Tumor Suppressor Proteins * genetics MeSH
- Pancreatic Neoplasms * genetics pathology MeSH
- Case-Control Studies MeSH
- Transcription Factors genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Names of Substances
- Forkhead Transcription Factors MeSH
- FOXA1 protein, human MeSH Browser
- FOXP3 protein, human MeSH Browser
- Hepatocyte Nuclear Factor 3-alpha MeSH
- Biomarkers, Tumor * MeSH
- Tumor Suppressor Proteins * MeSH
- TP63 protein, human MeSH Browser
- Transcription Factors MeSH
BACKGROUND: The genomes of present-day non-Africans are composed of 1-3% of Neandertal-derived DNA as a consequence of admixture events between Neandertals and anatomically modern humans about 50-60 thousand years ago. Neandertal-introgressed single nucleotide polymorphisms (aSNPs) have been associated with modern human disease-related traits, which are risk factors for pancreatic ductal adenocarcinoma (PDAC), such as obesity, type 2 diabetes, and inflammation. In this study, we aimed at investigating the role of aSNPs in PDAC in three Eurasian populations. RESULTS: The high-coverage Vindija Neandertal genome was used to select aSNPs in non-African populations from 1000 Genomes project phase 3 data. Then, the association between aSNPs and PDAC risk was tested independently in Europeans and East Asians, using existing GWAS data on more than 200 000 individuals. We did not find any significant associations between aSNPs and PDAC in samples of European descent, whereas, in East Asians, we observed that the Chr10p12.1-rs117585753-T allele (MAF = 10%) increased the risk to develop PDAC (OR = 1.35, 95%CI 1.19-1.54, P = 3.59 × 10-6), with a P-value close to a threshold that takes into account multiple testing. CONCLUSIONS: Our results show only a minimal contribution of Neandertal SNPs to PDAC risk.
- Keywords
- Admixture, Association study, Eurasians, Introgression, Neandertal, Pancreatic cancer,
- MeSH
- Diabetes Mellitus, Type 2 * MeSH
- Carcinoma, Pancreatic Ductal * genetics MeSH
- Polymorphism, Single Nucleotide MeSH
- Humans MeSH
- Pancreatic Neoplasms * genetics MeSH
- Neanderthals * genetics MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH